Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trial

Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trial

Summary: Background: Vaccination has helped to mitigate the COVID-19 pandemic. Ten traditional and novel vaccines have been listed by the World Health Organization for emergency use. Additional alternative approaches may better address ongoing vaccination globally, where there remains an inequity i...

Full description

Bibliographic Details
Main Authors:	Joon Young Song, Won Suk Choi, Jung Yeon Heo, Jin Soo Lee, Dong Sik Jung, Shin-Woo Kim, Kyung-Hwa Park, Joong Sik Eom, Su Jin Jeong, Jacob Lee, Ki Tae Kwon, Hee Jung Choi, Jang Wook Sohn, Young Keun Kim, Ji Yun Noh, Woo Joo Kim, François Roman, Maria Angeles Ceregido, Francesca Solmi, Agathe Philippot, Alexandra C. Walls, Lauren Carter, David Veesler, Neil P. King, Hun Kim, Ji Hwa Ryu, Su Jeen Lee, Yong Wook Park, Ho Keun Park, Hee Jin Cheong
Format:	Article
Language:	English
Published:	Elsevier 2022-09-01
Series:	EClinicalMedicine
Subjects:	SARS-CoV-2 COVID-19 Recombinant protein vaccine Nanoparticle vaccine Humoral immunity Cellular immunity
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589537022002991

Similar Items

Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: interim results of a randomised, active-controlled, observer-blinded, phase 3 trialResearch in context
by: Joon Young Song, et al.
Published: (2023-10-01)

Respiratory syncytial virus infection and the need for immunization in Korea
by: Hye Young Kim, et al.
Published: (2023-12-01)

Factors Influencing Vaccination in Korea: Findings From Focus Group Interviews
by: Bomi Park, et al.
Published: (2018-07-01)

Effects of influenza immunization on pneumonia in the elderly
by: Jung Yeon Heo, et al.
Published: (2018-03-01)

Changes in vaccination practices among infants after the introduction of DTaP-IPV/Hib combination vaccines
by: Hee-Jin Kim, et al.
Published: (2024-06-01)

Six-month longitudinal immune kinetics after mRNA-1273 vaccination: Correlation of peak antibody response with long-term, cross-reactive immunity
by: Min Joo Choi, et al.
Published: (2023-01-01)

Post-vaccination Monitoring to Assess Foot-and-Mouth Disease Immunity at Population Level in Korea
by: Mi-Young Park, et al.
Published: (2021-08-01)

Global varicella vaccination programs
by: Young Hwa Lee, et al.
Published: (2022-12-01)

Cross-Sectional Study of Varicella Zoster Virus Immunity in Healthy Korean Children Assessed by Glycoprotein Enzyme-Linked Immunosorbent Assay and Fluorescent Antibody to Membrane Antigen Test
by: Yunhwa Kim, et al.
Published: (2021-05-01)

Humoral and cellular immunogenicity of homologous and heterologous booster vaccination in Ad26.COV2.S-primed individuals: Comparison by breakthrough infection
by: Hakjun Hyun, et al.
Published: (2023-03-01)

Self-Assembled Multi-Epitope Peptide Amphiphiles Enhance the Immune Response against Enterovirus 71
by: Yu-Gyeong Kim, et al.
Published: (2020-11-01)

A Lesson from a Measles Outbreak among Healthcare Workers in a Single Hospital in South Korea: The Importance of Knowing the Prevalence of Susceptibility
by: Sungim Choi, et al.
Published: (2023-09-01)

Reply letter: trends in varicella and herpes zoster epidemiology before and after the implementation of universal one-dose varicella vaccination over one decade in South Korea, 2003-2015
by: Sun Hee Park, et al.
Published: (2019-11-01)

Pediatric humoral immune responses and infection risk after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and two-dose vaccination during SARS-CoV-2 omicron BA.5 and BN.1 variants predominance in South Korea
by: Hyun-Woo Choi, et al.
Published: (2023-12-01)

Intradermal Inoculation of Inactivated Foot-and-Mouth Disease Vaccine Induced Effective Immune Responses Comparable to Conventional Intramuscular Injection in Pigs
by: Simin Lee, et al.
Published: (2024-02-01)

Humoral and Cellular Immune Responses to Vector, Mix-and-Match, or mRNA Vaccines against SARS-CoV-2 and the Relationship between the Two Immune Responses
by: Minjeong Nam, et al.
Published: (2022-08-01)

Presumed population immunity to SARS-CoV-2 in South Korea, April 2022
by: Eun Jung Jang, et al.
Published: (2022-10-01)

Comparison of Humoral Response between Third and Fourth Doses of COVID-19 Vaccine in Hemodialysis Patients
by: Yoosun Joo, et al.
Published: (2023-10-01)

Recommendation for the use of newly introduced Tdap vaccine in Korea
by: Kyong Min Choi, et al.
Published: (2011-04-01)

Application of ZnO-Based Nanocomposites for Vaccines and Cancer Immunotherapy
by: Prashant Sharma, et al.
Published: (2019-09-01)

A Structural View at Vaccine Development against <i>M. tuberculosis</i>
by: Maria Romano, et al.
Published: (2023-01-01)

Systemic and Oral Immunogenicity of Porcine Epidemic Diarrhea Virus Antigen Fused to Poly-Fc of Immunoglobulin G and Expressed in ΔXT/FT Nicotiana benthamiana Plants
by: Nguyen-Quang-Duc Tien, et al.
Published: (2021-04-01)

MERS-CoV Spike Protein Vaccine and Inactivated Influenza Vaccine Formulated with Single Strand RNA Adjuvant Induce T-Cell Activation through Intranasal Immunization in Mice
by: Hye-Jung Kim, et al.
Published: (2020-05-01)

Retention of neutralizing antibodies to Japanese encephalitis vaccine in age groups above fifteen years in Korea
by: Hee-Jung Lee, et al.
Published: (2020-11-01)

Korean Red Ginseng Potentially Improves Maintaining Antibodies after COVID-19 Vaccination: A 24-Week Longitudinal Study
by: Jihyun Yoon, et al.
Published: (2023-03-01)

Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in HIV-infected adults in the era of highly active antiretroviral therapy: analysis stratified by CD4 T-cell count
by: Joon Young Song, et al.
Published: (2020-01-01)

Recommendation for use of the newly introduced pneumococcal protein conjugate vaccines in Korea
by: Eun Hwa Choi, et al.
Published: (2011-04-01)

Baculovirus Vector-Based Varicella-Zoster Virus Vaccine as a Promising Alternative with Enhanced Safety and Therapeutic Functions
by: Chanyeong Lee, et al.
Published: (2024-03-01)

Kinetics of vaccine-induced neutralizing antibody titers and estimated protective immunity against wild-type SARS-CoV-2 and the Delta variant: A prospective nationwide cohort study comparing three COVID-19 vaccination protocols in South Korea
by: Eliel Nham, et al.
Published: (2022-09-01)

Comparison of humoral and cellular immune responses between ChAd-BNT heterologous vaccination and BNT-BNT homologous vaccination following the third BNT dose: A prospective cohort study
by: Wooho Sim, et al.
Published: (2023-03-01)

Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis
by: Ah Young Kim, et al.
Published: (2022-06-01)

Estimating the Total Societal Cost of a Hexavalent Vaccine versus a Pentavalent Vaccine with Hepatitis B in South Korea
by: Serim Min, et al.
Published: (2023-05-01)

COVID-19 vaccine type-dependent differences in immunogenicity and inflammatory response: BNT162b2 and ChAdOx1 nCoV-19
by: Jung Yeon Heo, et al.
Published: (2022-09-01)

Impact of Media Coverage on Influenza Vaccine Coverage in Elderly Individuals from 2020 to 2021 in the Republic of Korea
by: Yunhyung Kwon, et al.
Published: (2021-04-01)

Efficacy of White Spot Syndrome Virus Protein VP28-Expressing <i>Chlorella vulgaris</i> as an Oral Vaccine for Shrimp
by: Min-Jeong Kim, et al.
Published: (2023-09-01)

BCG Cell Wall Skeleton As a Vaccine Adjuvant Protects Both Infant and Old-Aged Mice from Influenza Virus Infection
by: Ki-Hye Kim, et al.
Published: (2021-05-01)

Predictors of COVID-19 booster vaccine hesitancy among fully vaccinated adults in Korea: a nationwide cross-sectional survey
by: Yunha Noh, et al.
Published: (2022-07-01)

Incidence of varicella in children in Jeju-do, Korea, 2005-2016: age-period-cohort analysis
by: Jinhee Kim, et al.
Published: (2018-11-01)

Evaluation of cell-surface displayed synthetic consensus dengue EDIII cells as a potent oral vaccine candidate
by: Jyotiranjan Bal, et al.
Published: (2018-09-01)

Establishment of Three-Dimensional Bioprinted Bladder Cancer-on-a-Chip with a Microfluidic System Using Bacillus Calmette–Guérin
by: Jung Hoon Kim, et al.
Published: (2021-08-01)